|
Engineering investigation: as no product was returned an analysis of the balloon rupture could not be conducted.The details indicate that there was difficulty advancing the introducer sheath due to the patient's heavily calcified anatomy.The details do not indicate that the lesion was pre dilated prior to advancement of the icast deliver system to the target.A full review of the catheter lot history records for the devices in question was performed.The records indicate that this lot of catheters passed atriums final lot qualification testing.This inspection requires that the catheter lot must pass the following: ability of the stent and delivery system to be passed through the labeled introducer sheath.Ability to deploy the stent at nominal pressure (8atm).Ability to withdraw the deflated balloon catheter back through the labeled introducer sheath ability of the delivery system to withstand 5 inflate/deflate cycles at the rated burst pressure (12atm) without leaks or failures.Balloon burst testing.The balloon must burst over the rated burst pressure specified on the label (12atm).Result: all quality inspection samples passed this final inspection without any non-conformances noted during the final lot qualification testing associated with the complaint.In addition to the final lot qualification testing there are multiple in-process inspections conducted that include the following: balloon hole skive dimensional verification.Stent securement testing.Proximal balloon weld tensile testing.Distal tip tensile testing.Catheter leak check.Result: all quality inspection samples passed this final inspection without any non-conformances noted during the final lot qualification testing.A review of the balloon burst test data that was generated during the balloon forming process as well as after stent deployment as part of the lot qualification testing indicates that out of a total of 49 samples tested, the lowest burst volume was 19.2 atm.This value far exceeds the product burst pressure of 12 atm as specified on the product label.Conclusion: the details provided within the complaint indicate that the patient's anatomy was very badly calcified.It is possible that the balloon ruptured on the calcified anatomy upon the deployment of the stent.Based on the passing results of the device history records review, atrium medical can find no fault with the device in question.Clinical evaluation: endovascular aortic aneurysm repair (evar) is a minimally invasive procedure that is used to treat an abdominal aortic aneurysm.The procedure includes placement of a large endograft within the aorta and stent placement into the adjacent arteries as protection from occlusion by the graft.The graft is then secured via fixation barbs to prevent migration.Balloon ruptures may occur in endovascular aneurysm repairs because they may come in contact with the fixation barbs and the grafts/stents are subjected to forces due to cardiopulmonary movement of the viscera and of the endograft.If the fenestrated endograft is not perfectly positioned within the native anatomy the device will be subjected to additional forces as they are forced to realign to accommodate the geometrical mismatch.The instructions for use (ifu): as with all procedures that utilize techniques for introducing a catheter, complications may be expected.Similarly, complications and adverse events can occur when using any endoluminal device.These include, but are not limited to: misplacement, migration, infection, septic shock, occlusion, perforation or hemorrhage.
|